
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
InvAscent is the investment advisor to EILSF (Fund I), India Life Sciences Fund II (ILSF-II) and India Life Sciences Fund III (ILSF-III). These funds provide private equity growth capital to companies in the Indian pharmaceutical, healthcare, animal health and medtech industries. Examples of funds usage include capacity expansion, introduction of new products, acquisitions, etc. The typical investment size is in the range of USD 10 - 40 million over the life of the investment for a significant minority stake. Fund-I made 8 investments during the period 2007-12 and has exited all 8 investments. ILSF-II is partially exited with 12 investments...
Pharmaceutical investing and healthcare investing
Invascent operates in the Venture capital and private equity principals industry.
Invascent's revenue is 11m - 100m
Invascent has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.